Lofexidine

Modify Date: 2024-01-04 23:08:25

Lofexidine Structure
Lofexidine structure
Common Name Lofexidine
CAS Number 31036-80-3 Molecular Weight 259.132
Density 1.4±0.1 g/cm3 Boiling Point 421.5±35.0 °C at 760 mmHg
Molecular Formula C11H12Cl2N2O Melting Point 215-225 °C
MSDS N/A Flash Point 208.7±25.9 °C

 Use of Lofexidine


Lofexidine is a selective α2-receptor agonist, commonly used to alleviate the physical symptoms of heroin and other types of opioid withdrawal[1][2].

 Names

Name lofexidine
Synonym More Synonyms

 Lofexidine Biological Activity

Description Lofexidine is a selective α2-receptor agonist, commonly used to alleviate the physical symptoms of heroin and other types of opioid withdrawal[1][2].
Related Catalog
Target

α2-receptor[1][2].

References

[1]. Vartak AP, et al. The preclinical discovery of lofexidine for the treatment of opiate addiction. Expert Opin Drug Discov. 2014 Nov;9(11):1371-7.

[2]. Gish EC, et al. Lofexidine, an {alpha}2-receptor agonist for opioid detoxification. Ann Pharmacother. 2010 Feb;44(2):343-51.

 Chemical & Physical Properties

Density 1.4±0.1 g/cm3
Boiling Point 421.5±35.0 °C at 760 mmHg
Melting Point 215-225 °C
Molecular Formula C11H12Cl2N2O
Molecular Weight 259.132
Flash Point 208.7±25.9 °C
Exact Mass 258.032654
PSA 33.62000
LogP 3.59
Vapour Pressure 0.0±1.0 mmHg at 25°C
Index of Refraction 1.611
Storage condition -20°C

 Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
NJ2568000
CHEMICAL NAME :
2-Imidazoline 2-(1-(2,6-dichlorophenoxy)ethyl)-
CAS REGISTRY NUMBER :
31036-80-3
LAST UPDATED :
198912
DATA ITEMS CITED :
2
MOLECULAR FORMULA :
C11-H12-Cl2-N2-O
MOLECULAR WEIGHT :
259.15

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Subcutaneous
DOSE :
8320 ug/kg
SEX/DURATION :
female 8-20 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Newborn - growth statistics (e.g.%, reduced weight gain)
REFERENCE :
NRTXDN Neurotoxicology. (Intox Press, Inc., POB 34075, Little Rock, AR 72203) V.1- 1979- Volume(issue)/page/year: 9,559,1988
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Subcutaneous
DOSE :
8320 ug/kg
SEX/DURATION :
female 8-20 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Newborn - biochemical and metabolic
REFERENCE :
NRTXDN Neurotoxicology. (Intox Press, Inc., POB 34075, Little Rock, AR 72203) V.1- 1979- Volume(issue)/page/year: 9,551,1988

 Safety Information

Safety Phrases S24/25
WGK Germany 3

 Synonyms

MFCD00865915
2-{1-[(2,6-dichlorophenyl)oxy]ethyl}-4,5-dihydro-1H-imidazole
2-(a-(2,6-dichlorophenoxy)ethyl)2-imidazoline
Lofexidinum [INN-Latin]
Lofexidina
1H-Imidazole, 2-[1-(2,6-dichlorophenoxy)ethyl]-4,5-dihydro-
Britlofex
Lofexidine
(±)-2-[1-(2,6-Dichlorophenoxy)ethyl]-2-imidazoline
Lofexidinum
Lofexidine [INN:BAN]
Lofexidina [INN-Spanish]
2-[1-(2,6-dichlorophenoxy)ethyl]-2-imidazoline
UNII:UI82K0T627
(-)-2-[1-(2,6-dichlorophenoxy)-ethyl]-1,3-diazacyclopent-2-ene
2-[1-(2,6-Dichlorophenoxy)ethyl]-4,5-dihydro-1H-imidazole
rac-2-[1-(2,6-dichlorophenoxy)ethyl]-1,3-diazacyclopent-2-ene